BNET Industries
- Private
- US
Dow Jones Description
Commodore Cornelius Vanderbilt had a vision of a place that would ?contribute to strengthening the ties that should exist between all sections of our common country? when he gave a million dollars to create a university in 1873. Today, that vision has been realized in Vanderbilt, an internationally recognized research university in Nashville, Tennessee, with strong partnerships among its 10 schools, neighboring institutions and the community. An independent, privately supported university, Vanderbilt is the largest private employer in Middle Tennessee and the second largest private employer based in the state.
Contact Information
2201 West End Avenue
Nashville, Tennessee 37235
(615) 322-7311
NAICS Code Colleges, Universities, and Professional Schools: 611310
Recent Events
-
Heard, Vanderbilt's fifth chancellor, dies at 92
-
Brett Sweet appointed Vanderbilt's chief financial officer
News & Analysis
Filter by
therapy and vanderbilt university - All News and Analysis
Amorcyte Cardiac Cell Therapy Trial Passes First Stage and Opens Two New Sites
- 2007-01-03
- Stem cell therapy trial proceeds to next stage and opens in two new clinical centers - HACKENSACK, N.J. -- Amorcyte, Inc. Amorcyte, a privately funded biotechnology company developing cell therapy products to treat cardiovascular disease, announced today that its phase I clinical trial is now open in two...
Vanderbilt University obtains United States patent.(Brief Article)
- 2003-09-01
Vanderbilt University (Nashville, TN) has patented a composition comprising a nuclear localization sequence and a peptide nucleic acid oligomer (NLS-PNA). Uses of the composition include, but are not limited to: regulation of gene expression, gene therapy, and the production of pharmaceutical nucleic acids and proteins. In...
Protein Predicts Cancer Prognosis.
- 2003-09-01
Many cancer scientists and physicians believe that using a "molecular fingerprint" of an individual's cancer may one day be used to diagnose that patient's disease and tailor therapy. Researchers at Vanderbilt University (Nashville, TN) have moved a step closer to that scenario with the identification of...
GENEMEDICINE Receives Broad Patent Covering the Use of Cationic Lipids for Gene Therapy
- 1997-10-15
THE WOODLANDS, Texas--BW HealthWire--October 15, 1997-- Worldwide exclusive license to Vanderbilt University patent issued in U.S. and in Europe covers widely used non-viral gene delivery technology GENEMEDICINE, INC. (NASDAQ:GMED) announced today the issuance both in the U.S. and in Europe of a major gene...
GeneMedicine establishes clinical trial agreement and broad-based research collaboration with Vanderbilt University to develop pulmonary gene therapies
- 1994-11-16
HOUSTON--BUSINESS WIRE--Nov. 16, 1994--GeneMedicine Inc. (NASDAQ:GMED) and Vanderbilt University Medical Center announced Wednesday the signing of both a cooperative research agreement for developing pulmonary gene therapy methods and a pulmonary gene therapy clinical trial agreement. GeneMedicine will collaborate with Vanderbilt's Center For Lung Research, and its Director,...
- 1
Glass Door
| Company | Employer Rating |
| Alcoa |  |
| CBS Corp |  |
| Johnson & Johnson | |
| Costco Wholesale |  |
|
IndustryTop Rated
